{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:31Z","timestamp":1778872171620,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Promotion Program grant of Nara Medical University","award":["JHR2100001"],"award-info":[{"award-number":["JHR2100001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1245\/s10434-026-19360-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:30:00Z","timestamp":1772721000000},"page":"5884-5896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluorescent Ureterorenoscopy-Assisted Thulium:YAG and Holmium:YAG Dual-Laser Ablation for Upper Urinary Tract Urothelial Carcinoma: Results of the FLUAM Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"Makito","family":"Miyake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Owari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Itami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Nakahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motokiyo","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"19360_CR1","first-page":"1148","volume":"46","author":"M Miyake","year":"2016","unstructured":"Miyake M, Tatsumi Y, Fujimoto K, et al. Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study. Jpn J Clin Oncol. 2016;46:1148\u201355.","journal-title":"Jpn J Clin Oncol."},{"key":"19360_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12957-020-01872-1","volume":"18","author":"M Miyake","year":"2020","unstructured":"Miyake M, Nishimura N, Aoki K, et al. Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer. World J Surg Oncol. 2020;18:104.","journal-title":"World J Surg Oncol."},{"key":"19360_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","volume":"87","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol. 2025;87:697\u2013716.","journal-title":"Eur Urol."},{"key":"19360_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","volume":"209","author":"JA Coleman","year":"2023","unstructured":"Coleman JA, Clark PE, Bixler BR, et al. Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline. J Urol. 2023;209:1071\u201381.","journal-title":"J Urol."},{"key":"19360_CR5","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol. 2016;70:1052\u201368.","journal-title":"Eur Urol."},{"key":"19360_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4111\/icu.20210113","volume":"62","author":"JM Farrow","year":"2021","unstructured":"Farrow JM, Kern SQ, Gryzinski GM, et al. Nephron-sparing management of upper tract urothelial carcinoma. Investig Clin Urol. 2021;62:389\u201398.","journal-title":"Investig Clin Urol."},{"key":"19360_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1089\/end.2019.0308","volume":"33","author":"L Defidio","year":"2019","unstructured":"Defidio L, Antonucci M, De Dominicis M, et al. Thulium-holmium:YAG duo laser in conservative upper tract urothelial cancer treatment: 13 years experience from a tertiary national referral center. J Endourol. 2019;33:902\u20138.","journal-title":"J Endourol."},{"key":"19360_CR8","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","volume":"110","author":"M Grasso","year":"2012","unstructured":"Grasso M, Fishman AI, Cohen J, et al. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int. 2012;110:1618\u201326.","journal-title":"BJU Int."},{"key":"19360_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.urology.2018.05.042","volume":"121","author":"KB Scotland","year":"2018","unstructured":"Scotland KB, Kleinmann N, Cason D, et al. Ureteroscopic management of large \u22652 cm upper tract urothelial carcinoma: a comprehensive 23-year experience. Urology. 2018;121:66\u201373.","journal-title":"Urology."},{"key":"19360_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/end.2017.0915","volume":"32","author":"G Musi","year":"2018","unstructured":"Musi G, Mistretta FA, Marenghi C, et al. Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes. J Endourol. 2018;32:257\u201363.","journal-title":"J Endourol."},{"key":"19360_CR11","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00345-023-04687-3","volume":"41","author":"T Tsujino","year":"2023","unstructured":"Tsujino T, Komura K, Inamoto T, et al. Nephron-sparing ureteroscopic surgery vs radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma. World J Urol. 2023;41:3585\u201391.","journal-title":"World J Urol."},{"key":"19360_CR12","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.3390\/cancers16223795","volume":"16","author":"S Bislev","year":"2024","unstructured":"Bislev S, Brandt SB, Fuglsig S, et al. Local endoscopic treatment of low-grade urothelial tumors in the upper urinary tract-oncological outcome of a consecutive single-center series of 118 patients. Cancers Basel. 2024;16:3795.","journal-title":"Cancers Basel."},{"key":"19360_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","volume":"34","author":"L Villa","year":"2016","unstructured":"Villa L, Cloutier J, Letendre J, et al. Early repeated ureteroscopy within 6\u20138 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol. 2016;34:1201\u20136.","journal-title":"World J Urol."},{"key":"19360_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.aju.2017.01.003","volume":"15","author":"E Osman","year":"2017","unstructured":"Osman E, Alnaib Z, Kumar N. Photodynamic diagnosis in upper urinary tract urothelial carcinoma: a systematic review. Arab J Urol. 2017;15:100\u20139.","journal-title":"Arab J Urol."},{"key":"19360_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euros.2021.03.009","volume":"28","author":"T Yoshida","year":"2021","unstructured":"Yoshida T, Murota T, Matsuzaki T, et al. Photodynamic diagnosis\u2013guided dual laser ablation for upper urinary tract carcinoma: preoperative preparation, surgical technique, and clinical outcomes. Eur Urol Open Sci. 2021;28:17\u201325.","journal-title":"Eur Urol Open Sci."},{"key":"19360_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2019.101617","volume":"29","author":"H Fukuhara","year":"2020","unstructured":"Fukuhara H, Kurabayashi A, Furihata M, et al. 5-Aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma preliminary prospective single centre trial. Photodiagn Photodyn Ther. 2020;29:101617.","journal-title":"Photodiagn Photodyn Ther."},{"key":"19360_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/end.2019.0725","volume":"34","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Setsuda S, Ishizuka M, et al. Photodynamic diagnosis with oral 5-aminolevulinic acid for upper urinary tract carcinoma: a prospective clinical trial. J Endourol. 2020;34:509\u201315.","journal-title":"J Endourol."},{"key":"19360_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2022.100902","volume":"26","author":"M Miyake","year":"2022","unstructured":"Miyake M, Yoshida T, Nishimura N, et al. A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: study protocol of the FLUAM trial. Contemp Clin Trials Commun. 2022;26:100902.","journal-title":"Contemp Clin Trials Commun."},{"key":"19360_CR19","doi-asserted-by":"crossref","unstructured":"Paner GP, Stadler WM, Hansel DE, et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73:560\u20139","DOI":"10.1016\/j.eururo.2017.12.018"},{"key":"19360_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis."},{"key":"19360_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/diagnostics11020185","volume":"11","author":"M Miyake","year":"2021","unstructured":"Miyake M, Nishimura N, Nakai Y, et al. Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases the risk of repeated recurrence in non-muscle-invasive bladder cancer: a cumulative incidence analysis by the person-time method. Diagnostics Basel. 2021;11:185.","journal-title":"Diagnostics Basel."},{"key":"19360_CR22","doi-asserted-by":"publisher","first-page":"23128","DOI":"10.1038\/s41598-024-72755-8","volume":"14","author":"M Miyake","year":"2024","unstructured":"Miyake M, Nishimura N, Oda Y, et al. Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors. Sci Rep. 2024;14:23128.","journal-title":"Sci Rep."},{"key":"19360_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/end.2020.0371","volume":"35","author":"M Miyake","year":"2021","unstructured":"Miyake M, Nishimura N, Fujii T, et al. Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for nonmuscle invasive bladder cancer: short-term oncologic and functional outcomes. J Endourol. 2021;35:319\u201327.","journal-title":"J Endourol."},{"key":"19360_CR24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582\u201392.","journal-title":"Med Care."},{"key":"19360_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/08927790251387367","volume":"39","author":"M Miyake","year":"2025","unstructured":"Miyake M, Shimizu T, Nishimura N, et al. Clinical utility of ureteral optical coherence tomography for T staging of ureteral cancer: NOCTURN study. J Endourol. 2025;39:1276\u201384.","journal-title":"J Endourol."},{"key":"19360_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.euros.2023.11.005","volume":"59","author":"C Giulioni","year":"2023","unstructured":"Giulioni C, Pirola GM, Maggi M, et al. Current evidence on utility, outcomes, and limitations of endoscopic laser ablation for localized upper urinary tract urothelial carcinoma: results from a scoping review. Eur Urol Open Sci. 2023;59:7\u201317.","journal-title":"Eur Urol Open Sci."},{"key":"19360_CR27","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1089\/end.2021.0133","volume":"35","author":"F Sanguedolce","year":"2021","unstructured":"Sanguedolce F, Fontana M, Turco M, et al. Endoscopic management of upper urinary tract urothelial carcinoma: oncologic outcomes and prognostic factors in a contemporary cohort. J Endourol. 2021;35:1593\u2013600.","journal-title":"J Endourol."},{"key":"19360_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pdpdt.2015.08.002","volume":"13","author":"SG Kata","year":"2016","unstructured":"Kata SG, Aboumarzouk OM, Zreik A, et al. Photodynamic diagnostic ureterorenoscopy: a valuable tool in the detection of upper urinary tract tumour. Photodiagn Photodyn Ther. 2016;13:255\u201360.","journal-title":"Photodiagn Photodyn Ther."},{"key":"19360_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.21037\/tau-2025-27","volume":"14","author":"M Miyake","year":"2025","unstructured":"Miyake M. Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladder. Transl Androl Urol. 2025;14:872\u20136.","journal-title":"Transl Androl Urol."},{"key":"19360_CR30","first-page":"251","volume":"10","author":"M Miyake","year":"2018","unstructured":"Miyake M, Owari T, Hori S, et al. Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma. Res Rep Urol. 2018;10:251\u201361.","journal-title":"Res Rep Urol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19360-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:29Z","timestamp":1778869649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19360-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19360"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19360-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Miyake M. and Fujimoto K. received 5-aminolevulinic acid hydrochloride from SBI Pharmaceuticals Co., Ltd. during the performance of the study. Both authors received a joint research fund from SBI Pharmaceuticals Co., Ltd. outside the submitted study (the AMBER study; the Japan Registry of Clinical Trials ID jRCTs051190077). The remaining authors have no disclosure.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This clinical trial complied with the Declaration of Helsinki regarding investigation in humans. Its ethical clearance and protocol (version 1.0 on 21 June 2021), including the subject information, informed consent forms, and associated documents, were approved by the Certified Review Board of Nara Medical University (institution ID: CRB5200002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent and written consent forms of patients are mandatory before study participation. This clinical trial was prospectively registered with the Japan Registry of Clinical Trials on 28 June 2021 (reference no. jRCTs051210042). This trial complied with the Declaration of Helsinki for human investigations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}